Healthcare provider profile · identity verified

Jamison R Barber, GNP

Nurse Practitioner · MINNEAPOLIS, MN · NPI 1689616336

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	307	40
Quetiapine Fumarate	Quetiapine Fumarate	302	39
Metoprolol Succinate	Metoprolol Succinate	284	37
Mirtazapine	Mirtazapine	268	32
Levothyroxine Sodium	Levothyroxine Sodium	264	29
Trazodone Hcl	Trazodone Hcl	257	37
Citalopram Hbr	Citalopram Hydrobromide	255	31
Lisinopril	Lisinopril	251	31
Sertraline Hcl	Sertraline Hcl	231	28
Furosemide	Furosemide	229	34
Omeprazole	Omeprazole	219	28
Eliquis	Apixaban	203	29
Amlodipine Besylate	Amlodipine Besylate	197	28
Gabapentin	Gabapentin	193	32
Potassium Chloride	Potassium Chloride	193	29
Donepezil Hcl	Donepezil Hcl	162	25
Escitalopram Oxalate	Escitalopram Oxalate	132	17
Memantine Hcl	Memantine Hcl	118	16
Rosuvastatin Calcium	Rosuvastatin Calcium	115	15
Pantoprazole Sodium	Pantoprazole Sodium	113	15
Jantoven	Warfarin Sodium	106	suppressed
Duloxetine Hcl	Duloxetine Hcl	94	11
Tamsulosin Hcl	Tamsulosin Hcl	91	14
Metoprolol Tartrate	Metoprolol Tartrate	88	suppressed
Losartan Potassium	Losartan Potassium	81	14
Buspirone Hcl	Buspirone Hcl	80	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	79	suppressed
Tramadol Hcl	Tramadol Hcl	78	24
Simvastatin	Simvastatin	75	suppressed
Levetiracetam	Levetiracetam	73	suppressed
Pravastatin Sodium	Pravastatin Sodium	71	suppressed
Finasteride	Finasteride	70	suppressed
Latanoprost	Latanoprost	70	11
Oxycodone Hcl	Oxycodone Hcl	67	13
Nystatin	Nystatin	63	21
Olanzapine	Olanzapine	61	suppressed
Warfarin Sodium	Warfarin Sodium	60	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	56	suppressed
Spironolactone	Spironolactone	52	suppressed
Digoxin	Digoxin	50	suppressed
Torsemide	Torsemide	49	suppressed
Allopurinol	Allopurinol	46	suppressed
Bupropion Xl	Bupropion Hcl	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	suppressed
Jardiance	Empagliflozin	43	suppressed
Olanzapine Odt	Olanzapine	43	suppressed
Rivastigmine	Rivastigmine	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	13
Aripiprazole	Aripiprazole	40	suppressed
Chlorthalidone	Chlorthalidone	39	suppressed
Cephalexin	Cephalexin	37	22
Myrbetriq	Mirabegron	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Metformin Hcl	Metformin Hcl	34	suppressed
Divalproex Sodium	Divalproex Sodium	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Lorazepam	Lorazepam	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Baclofen	Baclofen	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Risperidone	Risperidone	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Famotidine	Famotidine	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Hydrocortisone	Hydrocortisone	26	11
Ondansetron Odt	Ondansetron	26	20
Carvedilol	Carvedilol	25	suppressed
Timolol Maleate	Timolol Maleate	25	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	14
Rivastigmine	Rivastigmine Tartrate	22	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Sotalol	Sotalol Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Loperamide	Loperamide Hcl	15	12
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Clonidine	Clonidine	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Gemtesa	Vibegron	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Prednisone	Prednisone	13	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Budesonide Dr	Budesonide	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Letrozole	Letrozole	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error